Bath & Body Works, Inc.: Form 10-K for the period ended Jan 29, 2011
Filed with the SEC on Mar 18, 2011 and accepted by EDGAR at Mar 18, 2011, 20:09 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2011-01-29. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2010-10-31 to 2011-01-29 | $3.46bn | us-gaap:SalesRevenueNet |
| Revenue | 12 months2010-01-31 to 2011-01-29 | $9.61bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 12 months2010-01-31 to 2011-01-29 | $5.98bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2010-10-31 to 2011-01-29 | $1.45bn | us-gaap:GrossProfit |
| Gross profit | 12 months2010-01-31 to 2011-01-29 | $3.63bn | us-gaap:GrossProfit |
| Selling, general and administrative | 12 months2010-01-31 to 2011-01-29 | $2.34bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2010-10-31 to 2011-01-29 | $714.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 12 months2010-01-31 to 2011-01-29 | $1.28bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2010-01-31 to 2011-01-29 | $208.0m | us-gaap:InterestExpense |
| Income tax | 12 months2010-01-31 to 2011-01-29 | $446.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2010-10-31 to 2011-01-29 | $453.0m | us-gaap:NetIncomeLoss |
| Net income | 12 months2010-01-31 to 2011-01-29 | $805.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2010-01-31 to 2011-01-29 | $2.42 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2010-01-31 to 2011-01-29 | $2.49 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2010-01-31 to 2011-01-29 | 333,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2010-01-31 to 2011-01-29 | $1.28bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2010-01-31 to 2011-01-29 | $274.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2010-01-31 to 2011-01-29 | $1.49bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2010-01-31 to 2011-01-29 | $207.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2011-01-29 | $1.13bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2011-01-29 | $2.59bn | us-gaap:AssetsCurrent |
| Total assets | At period end2011-01-29 | $6.45bn | us-gaap:Assets |
| Current liabilities | At period end2011-01-29 | $1.50bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2011-01-29 | $2.51bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2011-01-29 | $0 | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2011-01-29 | $1.48bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-11-071220. Last ingested by Listed: Nov 13, 2026, 16:03 ET. Listed shows no prices and gives no investment advice.